Cargando…
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
Cyclooxygenase type-2 (COX-2) is overexpressed in malignant tumours including breast cancers, though the mechanism of upregulation is unclear. This study aimed to determine COX-2 expression in ductal carcinoma in situ (DCIS) in comparison to invasive breast cancer (IBC) and normal breast, and also t...
Autores principales: | Boland, G P, Butt, I S, Prasad, R, Knox, W F, Bundred, N J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409574/ https://www.ncbi.nlm.nih.gov/pubmed/14735188 http://dx.doi.org/10.1038/sj.bjc.6601534 |
Ejemplares similares
-
Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003) -
Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002) -
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004) -
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006) -
Impaired ΔNp63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms
por: Koga, F, et al.
Publicado: (2003)